Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY18.86 CNY
Change Today +0.98 / 5.48%
Volume 30.8M
601607 On Other Exchanges
Symbol
Exchange
Shanghai
Berlin
OTC US
OTC US
Hong Kong
As of 3:05 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for shanghai pharmaceuticals-a (601607)

Year over year, Shanghai Pharmaceuticals Holding Co., Ltd. has been able to grow revenues from CNY78.2B CNY to CNY92.4B CNY. Most impressively, the company has been able to reduce the percentage of sales devoted to selling, general and administrative costs from 9.32% to 8.78%. This was a driver that led to a bottom line growth from CNY2.2B CNY to CNY2.6B CNY.
View Income Statement In U.S. Dollar
Currency in
Millions of Chinese Renminbi (Yuan)s
As of:Dec 31
2011
CNY
Dec 31
2012
Reclassified
CNY
Dec 31
2013
Restated
CNY
Dec 31
2014
CNY
4 Year
Trend
Revenues54,899.968,078.178,222.892,398.9
TOTAL REVENUES54,899.968,078.178,222.892,398.9
Cost of Goods Sold47,043.458,980.368,185.881,223.4
GROSS PROFIT7,856.59,097.810,037.011,175.5
Selling General & Admin Expenses, Total5,476.86,502.47,287.98,112.2
OTHER OPERATING EXPENSES, TOTAL5,476.86,502.47,287.98,112.2
OPERATING INCOME2,379.62,595.42,749.13,063.3
Interest Expense-461.8-472.4-413.7-584.9
Interest and Investment Income265.4306.4311.4260.5
NET INTEREST EXPENSE-196.4-166.0-102.4-324.4
Income (Loss) on Equity Investments303.8338.4399.4413.0
Currency Exchange Gains (Loss)-194.616.47.5-11.0
Other Non-Operating Income (Expenses)58.3148.1119.0160.6
EBT, EXCLUDING UNUSUAL ITEMS2,350.72,932.33,172.73,301.4
Impairment of Goodwill-1.0------
Gain (Loss) on Sale of Investments112.049.862.1160.6
Gain (Loss) on Sale of Assets525.9-13.91.4223.5
Other Unusual Items, Total47.5119.5-10.5114.2
Other Unusual Items51.7123.1-10.5114.2
EBT, INCLUDING UNUSUAL ITEMS3,035.13,087.73,225.63,799.7
Income Tax Expense589.1627.1628.4807.7
Minority Interest in Earnings-403.8-407.7-383.7-400.9
Earnings from Continuing Operations2,446.02,460.62,597.32,992.0
NET INCOME2,042.22,052.92,213.62,591.1
NET INCOME TO COMMON INCLUDING EXTRA ITEMS2,042.22,052.92,213.62,591.1
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS2,042.22,052.92,213.62,591.1
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
601607:CH CNY18.86 CNY +0.98

601607 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Huadong Medicine Co Ltd CNY76.44 CNY +3.64
Jointown Pharmaceutical Group Co Ltd CNY17.59 CNY +1.34
Nanjing Pharmaceutical Co Ltd CNY8.99 CNY +0.78
Wanjia Group Holdings Ltd $0.61 HKD +0.07
View Industry Companies
 

Industry Analysis

601607

Industry Average

Valuation 601607 Industry Range
Price/Earnings 17.0x
Price/Sales 0.5x
Price/Book 1.6x
Price/Cash Flow 12.2x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANGHAI PHARMACEUTICALS-A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.